Form 4: Baldwin Insurance Grants CEO 240,000 Restricted Shares

Baldwin Insurance Group, Inc. awarded James Morgan Roche, President and CEO of Underwriting, Capacity and Technology Operations, 240,000 restricted Class A common shares.

Summary

• James Morgan Roche, an officer of Baldwin Insurance Group, Inc. (BWIN), acquired 240,000 shares of Class A Common Stock.
• The acquisition occurred on February 26, 2026, and represents restricted shares granted at a price of $0.
• These restricted shares will vest in four equal installments on January 1, 2027, January 1, 2028, January 1, 2029, and January 1, 2030.
• The vesting is subject to the terms and conditions of Mr. Roche's restricted stock award agreement and his Second Amended and Restated Employment Agreement, dated February 26, 2026.
• Following this transaction, Mr. Roche beneficially owns 302,810 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine executive compensation disclosure, reflecting standard practices for aligning management incentives with long-term shareholder value, thus slightly positive for governance and retention.

Positives

• The grant of restricted stock aligns the long-term interests of a key executive, James Morgan Roche, with those of shareholders.
• This compensation structure serves as an incentive for executive retention and performance over a multi-year period.

Future Outlook

The future outlook indicates a structured long-term incentive plan for a key executive, with shares vesting over a four-year period from 2027 to 2030, contingent on the terms of his employment and award agreements.

Management Comments

• James Morgan Roche holds the titles of President, The Baldwin Group and CEO, Underwriting, Capacity and Technology Operations.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common and widely accepted form of executive compensation within the insurance industry and broader public markets. This practice aims to align the long-term financial interests of executives with the performance and value creation for shareholders, a standard approach to talent retention and motivation.

Comparison to Industry Standards

• The grant of restricted stock to a senior executive is a standard practice for publicly traded companies, including those in the insurance sector, to incentivize long-term performance and retention.
• The multi-year vesting schedule (four equal installments over four years) is typical for such awards, comparable to compensation structures seen at companies like Travelers Companies, Inc. or Chubb Limited, which often use similar long-term equity incentives for their leadership.

Related Party Transactions

• The grant of 240,000 restricted shares of Class A Common Stock to James Morgan Roche, an officer of the company, constitutes a related party transaction as part of his executive compensation.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through aligned executive incentives, balanced against future dilution upon vesting.
• Employees (specifically Mr. Roche): Receives significant long-term equity compensation, enhancing personal wealth and commitment to the company.

Next Steps

• Vesting of 60,000 restricted shares on January 1, 2027.
• Vesting of 60,000 restricted shares on January 1, 2028.
• Vesting of 60,000 restricted shares on January 1, 2029.
• Vesting of 60,000 restricted shares on January 1, 2030.

Key Dates

Recommendation

This Form 4 reports a standard executive compensation grant and does not provide new information that would alter the fundamental investment thesis for Baldwin Insurance Group, Inc. It is a routine disclosure that reinforces management's long-term commitment but does not warrant a change in investment recommendation based solely on this filing.

Keywords

Baldwin Insurance Group, BWIN, Restricted Stock, Executive Compensation, Form 4, Insider Trading, Stock Grant, Corporate Governance